Bortezomib FDA approval date

The FDA approved Bortezomib (Velcade) on 13 May 2003.

FDA approval date
13 May 2003

Drug identity checked against registry records

Also recorded as Velcade; Velcade®

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2003-05-13DayBortezomibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021602", "applicant_as_listed_by_fda": "TAKEDA PHARMS USA", "brand_names": ["VELCADE"], "active_ingredients": ["BORTEZOMIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20030513", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026